Mesala

trade name: mesala

active ingredient: mesalamaine Hcl

Form: enteric coated tablet – DR

package : 50  tablets

indications: inflammatory bowel disease

induction of remission in mild – moderate ulcerative colitis

maintenance of remission in ulcerative colitis

maintenance of remission in crohn’s disease

dosage : induction : 2.4 – 4.8 g/d in 3 divided doses

maintenance : 1.6 – 2.4 g/day in single dose or b.i.d

price : 75 LE

IMG-20130604-00353

Read More



Facebook